The pharma giant is betting on Ignyta's cancer drug, entrectinib, which is intended to treat patients with rare cancers.
Carlsbad’s Ionis Pharmaceuticals and Biogen have expanded their collaboration to identify new drug candidates for the treatment of spinal muscular atrophy (SMA).
MEDICINE: It Will Seek Closer Ties With UCSD Health, Bolster Marketing
The region’s first and only proton therapy center has relaunched under new ownership and management after a chapter 11 bankruptcy filing protection last spring.
The marine-centric biotech, which has now secured $1.68 million, will use the money to discover potential therapies to treat infectious diseases.
The agreements, which cover more than 3,000 employees who are seven months into working without a contract, must still be ratified.
The deal, expected to close during the first quarter of 2018, was unanimously approved by both companies’ boards.
The lead product candidate is a gene transfer drug to treat heart disease.
Wellness Cos. Help Care and Coverage Providers Find Ways to Effectively Reach and Influence Diverse Customer Bases
Swaying rural teens in Arkansas to stay away from chewing tobacco, a habit ingrained in the local culture, is no easy task. Nor is crafting relatable messages for teens on the dangers of prescription painkiller abuse.
San Diego’s Halozyme Therapeutics will receive a $40 million upfront payment, and potentially much more, as part of a collaboration and licensing deal with Alexion Pharmaceuticals.
San Diego biotech Metacrine, which is working on drugs for liver and metabolic diseases, has closed a $22 million Series B financing round.
California Protons is one of only two proton therapy centers in California and 25 nationwide.
San Diego biotech raised $10 million in a Series B round, led by investment from Illumina Ventures.
Yauvana Yoga & Float is set to open in January.
Human Longevity Inc. CEO Cynthia Collins is out after less than a year in the top spot at the San Diego-based genomics company.
BIOTECH: Challenges Are Big And Small in Testing on Animals
Explora Biolabs is part of San Diego’s biotech cluster. But CEO Richard Lin likens the company to a hotel.